Skip to main content
NewslettersWatchlist

Dbv Technologies ADR(DBVT-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low0.6900
Day High0.7000
Open:0.6998
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Why Shares of DBV Technologies Jumped Thursday
Motley Fool
Why DBV Technologies Stock Is Soaring Today
Barchart
Pre-Market Brief: Stocks Mixed As Strong Economic Data Fuel Rate Hike Worries
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DBV Technologies S.A. - DBVT
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DBV Technologies S.A. - DBVT
Globe Newswire
DBV Technologies Reports Second Quarter 2022 Financial Results
Globe Newswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
Globe Newswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2022
Motley Fool
2 Biotechs That Recently Soared -- Are They Buys?
Globe Newswire
DBV Technologies to Participate in Upcoming EAACI 2022 Congress
Globe Newswire
DBV Technologies to Present at the JMP Securities Life Sciences Conference in New York
Motley Fool
Why DBV Technologies Stock Popped Again Today
Globe Newswire
DBV Technologies Announces Private Placement Financing of $194 Million
Motley Fool
Why DBV Technologies Was a Big Winner on Wednesday
Globe Newswire
DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers
Globe Newswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2022
Globe Newswire
DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting
Globe Newswire
DBV Technologies Completes ADSs Sale of an amount of $15.3 million on Nasdaq through its At-The-Market program (ATM)
Globe Newswire
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
Globe Newswire
DBV Technologies Reports Recent Business Developments and First Quarter 2022 Financial Results
Globe Newswire
Correction: DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments
Globe Newswire
DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments
Globe Newswire
Ordinary and Extraordinary General Meeting of May 12, 2022
Globe Newswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2022
Globe Newswire
DBV Technologies to Present at the Oppenheimer’s 32nd Annual Healthcare Conference
Globe Newswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2022
Globe Newswire
DBV Technologies Announces Filing of 2021 Annual Report on Form 10-K and 2021 Universal Registration Document
Globe Newswire
DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Globe Newswire
DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022
Globe Newswire
DBV Technologies to Participate in Upcoming AAAAI 2022 Congress
Globe Newswire
DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Profile

DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut. The Company delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin. DBV Technologies SA is headquartered in Bagneux, France.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.